Steven Cohen Acadia Pharmaceuticals Inc Put Options Transaction History

Point72 Asset Management, L.P.

  • $39.3 Billion
  • Q1 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2018

May 15, 2018
SELL
$22.47 - $32.33 $2.25 Million - $3.23 Million
-100,000 Reduced 20.0%
400,000 $8.99 Million
Q3 2017

Nov 14, 2017
BUY
$29.49 - $38.37 $14.7 Million - $19.2 Million
500,000
500,000 $18.8 Million

Others Institutions Holding ACAD

# of Institutions
299
Shares Held
158M
Call Options Held
1.88M
Put Options Held
688K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.63B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email